David Stamler
Vermogen: 689 389 $ op 31-08-2026
Vermogen: 689 389 $ op 31-08-2026
Dr. David A. Stamler, MD, is a Chief Executive Officer, MD & Director at Alterity Therapeutics Ltd. He is on the Board of Directors at Alterity Therapeutics Ltd. Dr. Stamler was previously employed as a Vice President-Clinical Development & Therapeutic by Teva Pharmaceutical Industries Ltd., a Chief Medical Officer by Auspex Pharmaceuticals, Inc., a Chief Medical Officer & Senior Vice President by XenoPort, Inc., a Chief Scientific Officer & Head-Drug Development by Prestwick Pharmaceuticals, Inc., a Senior Global Project Leader-CNS Diseases by Fujisawa Pharmaceutical Co., Ltd., a Vice President- Clinical Research Center by Astellas Research Institute of America LLC, a Vice President-Research & Development by Fujisawa Healthcare, Inc., and a Director-Clinical Research by Abbott Laboratories.
He received his undergraduate degree from The University of Chicago and a doctorate degree from Pritzker School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-08-2026 | 1.904.863 ( 0,87% ) | 689 389 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ALTERITY THERAPEUTICS LIMITED | Algemeen Directeur | 07-01-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-01-2017 |
| AUSPEX PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 05-05-2015 |
| XENOPORT, INC. | Hoofd Techniek/Wetenschap/O&O | 19-11-2010 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Hoofd Techniek/Wetenschap/O&O | 01-01-2008 |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Corporate Officer/Principal | 01-01-2005 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Health Technology |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fujisawa Healthcare, Inc. | |
Astellas Research Institute of America LLC
Astellas Research Institute of America LLC Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical research & development company | Commercial Services |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau